
Historic news for the #mito community 💚
The FDA has approved the first-ever treatment for TK2d.
This follows the recent approval of Forzinity for Barth syndrome — progress is happening.
Full statement from IMP: mitopatients.org/new-drug-for-t…
#RareDisease #TK2d #MitochondrialDisease

English

































